Tellgen(SZ:300642) Xin Lang Cai Jing·2025-09-09 03:39Company Overview - Shanghai TuoJing Life Technology Co., Ltd. is located at 412 Huiqing Road, Pudong New District, Shanghai, established on November 6, 2003, and listed on April 21, 2017. The company specializes in the research, production, and sales of in vitro diagnostic products under its own brand [1]. Financial Performance - As of June 30, 2025, TuoJing Life reported a revenue of 159 million yuan, a year-on-year decrease of 26.25%, and a net profit attributable to shareholders of 2.76 million yuan, down 58.41% year-on-year [2]. - Cumulative cash dividends since the A-share listing amount to 264 million yuan, with 81.36 million yuan distributed over the past three years [3]. Stock Performance - On September 9, TuoJing Life's stock price fell by 2.02% to 25.70 yuan per share, with a trading volume of 108 million yuan and a turnover rate of 3.00%, resulting in a total market capitalization of 4.178 billion yuan [1]. - The stock has increased by 83.94% year-to-date, with a recent decline of 4.28% over the last five trading days, a 47.62% increase over the last 20 days, and a 79.72% increase over the last 60 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders is 16,000, a decrease of 6.19% from the previous period, with an average of 8,614 circulating shares per person, an increase of 6.60% [2]. - Among the top ten circulating shareholders, CITIC Prudential Multi-Strategy Mixed Fund (LOF) A ranks as the seventh largest shareholder, holding 1.2039 million shares as a new shareholder [3]. Market Position - TuoJing Life operates within the pharmaceutical and biotechnology sector, specifically in medical devices and in vitro diagnostics. The company is associated with several concept sectors, including share buybacks, DeepSeek concept, specialized and innovative enterprises, multiple births concept, and the Shanghai Free Trade Zone [1].